Phase 2 study of AKCEA-APOCIII-LRx in patients with hypertriglyceridaemia and established cardiovascular disease (CVD)

Educational partners and supporters (others pending)

Akcea Ionis logo 2021
Amarin Logo
Kowa Logo
Pfizer Logo